Fej-nyaki daganatok: vizsgálatok itt: Kína
217 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Chengdu
- Életkor
- 18 év to 75 év
- People
- 90
- Run by
- Lei Liu
See details and how to joinNCT06444009 - 2. fázisNot yet taking people in KínaNeoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 45
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06699498 - 3. fázisTaking peopleA Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
- Where
- Chengdu, Wuhan
- Életkor
- 18 év to 75 év
- People
- 510
- Run by
- Akeso
See details and how to joinNCT06601335 - 2. fázisTaking peopleSBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 35
- Run by
- Sun Yat-sen University
See details and how to joinNCT06611137 - 1. fázisTaking peopleU87 CAR-T in Patients With Advanced Head and Neck Tumors
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 20
- Run by
- Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
See details and how to joinNCT06614686 - No phaseTaking peopleEffects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma
- Where
- Guanzhou
- Életkor
- 18 év to 80 év
- People
- 302
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06575322 - 1/2. fázisTaking peopleDe-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 20
- Run by
- Ruijin Hospital
See details and how to joinNCT06572514 - 2. fázisTaking peopleARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
- Where
- Beijing, Changsha, Chengdu, Dalian, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Nanning, Shanghai, Shenyang, Tianjin, Wuhan, Xi’an, Xinjiang, Zhengzhou, Zhuhai
- Életkor
- 18 év and over
- People
- 170
- Run by
- Hansoh BioMedical R&D Company
See details and how to joinNCT06007729 - 2. fázisNot yet taking people in KínaTislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngeal Cancer
- Where
- Zhengzhou
- Életkor
- 18 év to 70 év
- People
- 46
- Run by
- Henan Cancer Hospital
See details and how to joinNCT06554028 - 2. fázisTaking peopleEfficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 100
- Run by
- Beijing Tongren Hospital
See details and how to joinNCT06100497 - 2. fázisTaking peopleMilaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
- Where
- Hangzhou
- Életkor
- 18 év to 65 év
- People
- 260
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT06534762 - 2/3. fázisTaking peopleTrans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
- Where
- Guanzhou
- Életkor
- 18 év and over
- People
- 200
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT03755739 - 1/2. fázisTaking peopleTriplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 100
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05187338 - No phaseTaking peopleGDFT on the Postoperative Outcome in Head and Neck Cancer Surgery
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 340
- Run by
- Beijing Tongren Hospital
See details and how to joinNCT06468852 - 2. fázisTaking peopleDe-Escalation Postoperative Radiotherapy for Oral Squamous Cell Carcinoma With pCR/MPR.
- Where
- Guangzhou
- Életkor
- 18 év to 80 év
- People
- 103
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06353685 - 3. fázisTaking peopleTislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I)
- Where
- Guanzhou, Shenzhen, Zhongshan
- Életkor
- 18 év to 80 év
- People
- 537
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT05582265 - 2. fázisTaking peopleTislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Clinically Node-negative Head and Neck Squamous Cell Carcinoma
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 154
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06323369 - 2. fázisTaking peopleResponse Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 133
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06345287 - 2. fázisTaking peopleNeoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)
- Where
- Guangzhou
- Életkor
- 18 év to 80 év
- People
- 43
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT05098119 - 2. fázisTaking peopleSBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 25
- Run by
- Sun Yat-sen University
See details and how to joinNCT06219980 - 2. fázisTaking peopleNeoadjuvant SBRT in Localized Advanced HNSCC
- Where
- Hangzhou
- Életkor
- 18 év to 70 év
- People
- 81
- Run by
- Jiang Feng
See details and how to joinNCT06306846 - No phaseTaking peoplePlasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis
- Where
- Fuzhou, Guangzhou, Huizhou, Jieyang, Meizhou
- Életkor
- 18 év and over
- People
- 300
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT06307314 - 2. fázisNot yet taking people in KínaMyeloprotection With Trilaciclib in Pan-cancer Population
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 132
- Run by
- Sun Yat-sen University
See details and how to joinNCT06297811 - 2. fázisTaking peopleA Prospective Randomized Controlled Study of Immune Checkpoint Maintenance Therapy After Radiotherapy and Chemotherapy for Locally Advanced Head and Neck Tumors Based on Peripheral Blood CD8Tex Detection in Peripheral Blood
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 104
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06240689 - 1. fázisTaking peopleHRYZ-T101 Injection for HPV18 Positive Solid Tumor
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 32
- Run by
- HRYZ Biotech Co.
See details and how to joinNCT05952947